Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
4.165
-0.175 (-4.03%)
May 12, 2025, 4:00 PM - Market closed
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $76.18 million as of May 12, 2025. Its market cap has increased by 26.34% in one year.
Market Cap
76.18M
Enterprise Value
64.64M
1-Year Change
26.34%
Ranking
Category
Stock Price
$4.17
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $76.18M, a decrease of -63.51%. That is a compound annual growth rate of -25.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 76.18M | -4.25% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |